Analysis of blood samples has revealed a set of proteins that appear years before prostate cancer is clinically detected. The proteins are connected to the immune system, cell adhesion processes, the formation of blood vessels and known prostate-cancer genes.Researchers found associations not only with overall risk of developing the disease but also with the likelihood of aggressive forms. The findings open the possibility of earlier risk stratification and more targeted monitoring for men who show elevated protein signatures.While the results are promising, further work is required to translate the protein panel into a practical screening tool. Any future test would need to demonstrate reliability across diverse populations and clear clinical utility before widespread adoption.The study adds to growing evidence that molecular changes detectable in blood can provide advance warning of certain cancers.
Blood Proteins May Signal Prostate Cancer Risk More Than a Decade Before Diagnosis
A large study has identified specific blood proteins linked to immune function, cell adhesion and blood-vessel formation that are associated with future prostate cancer risk, including aggressive forms of the disease.
